← Open Payments lookup

JASON JAVILLO: Open Payments

NPI 1366472557 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$548 in 28 payments from 13 companies in 2025. Trend: 2023 $74 · 2024 $628 · 2025 $548

Food & beverage: $548
CompanyPaymentsAmount
Novo Nordisk Inc6$128
GlaxoSmithKline, LLC.4$69
Lilly USA, LLC4$68
PFIZER INC.3$68
ABBVIE INC.2$41
Astellas Pharma US Inc2$39
Bayer Healthcare Pharmaceuticals Inc.1$24
E.R. Squibb & Sons, L.L.C.1$21
Gilead Sciences, Inc.1$21
SANOFI-AVENTIS U.S. LLC1$21

Products named: Ozempic, VYNDAQEL, MOUNJARO, QULIPTA, Veozah, Rybelsus, TRELEGY ELLIPTA, SHINGRIX.

Industry payments across MD — which companies pay providers there.